ENPNewswire-August 26, 2019--BeyondSpring's Plinabulin Demonstrates Superior Quality of Life over Pegfilgrastim
in a Head-to-Head Comparison Trial for the Prevention of Neutropenia
Fact.MR has announced the addition of the "Pegfilgrastim
Biosimilar Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 to 2028"report to their offering.
BeyondSpring announced the results of its head-to-head clinical trial for Study BPI-2358-105, accepted as an abstract titled, "Quality of Life in Advanced NSCLC Patients Treated with Docetaxel and with Either Plinabulin or Pegfilgrastim
for the Prevention of Neutropenia." The poster will be presented during the IASLC World Conference on Lung Cancer in Barcelona, Spain.
Nishant Saxena, CEO, International Business (Europe & Emerging Markets), Cipla, said: "This is a significant addition to our portfolio of offerings in the global biosimilars space which includes trastuzumab, bevacizumab, etanercept and pegfilgrastim
. Adalimumab is the highest-selling pharmaceutical product in the world and the preferred anti-inflammatory treatment option for several autoimmune diseases.
The analysis found that integrated efficacy and safety data from the two identically designed Phase 3 trials ADVANCE and Rolontiswere consistent with results from the individual trials, demonstrating that Rolontiswas non-inferior to pegfilgrastim
in the reduction of duration of severe neutropenia in all four cycles of treatment.
M2 EQUITYBITES-April 5, 2019-Sandoz resubmits Pegfilgrastim
Biologics License Application to the US Food and Drug Administration
Oncology partners The Mundipharma network reported on Friday the receipt of approval from the European Commission (EC) and the Committee for Medicinal Products for Human Use (CHMP) for Pelmeg (pegfilgrastim
) for reduction of neutropenia and febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy.
The announcement sees the Mundipharma network (including NAPP Pharmaceuticals in the UK) gain immediate access to Pelmeg (B12019), a biosimilar to Neulasta (pegfilgrastim
), which received CHMP recommendation for approval on 20 September 2018.
) is approved for patients with non-myeloid cancer who are receiving myelosuppressive chemotherapy and have symptoms of febrile neutropenia.
Then on Thursday, February 8, the day after he received a pegfilgrastim
injection, he was at home but extremely sluggish.
The 50-50joint venture was launched in 1984 to fund the global development of Epogen (epoetin alfa) and, over time, was expanded to include Neupogen (filgrastim), Neulasta (pegfilgrastim
), Aranesp (darbepoetin alfa), Nplate (romiplostim) and brodalumab.
FDA accepted Biocon's BLA for pegfilgrastim
for review, the company said in February.